IMPROLIP Canadian Trademark Information
Pharmaceutical preparations for the treatment of addiction, urinary incontinence, diabetes, cardiovascular diseases and disorders, cerebrovascular diseases and disorders, anxiety, depression, insomnia, cognitive disorders, diseases and disorders of the central nervous system namely central nervous system depressants and central nervous system stimulants, gastrointestinal diseases and disorders, cancer, obesity, inflammation and inflammatory diseases namely anti-inflammatories, respiratory diseases and disorders, musculoskeletal disorders namely connective tissue diseases, arthritis and rheumatic disorders, osteoporosis, menopausal symptoms and disorders, anti-infective preparations, anti-viral preparations, immunological preparations for the treatment of immunological deficiencies, hypersensitivity and other allergic disorders, analgesic preparations, ophthalmic preparations and antiemetic preparations.
Perfect for these industries
Words that describe this mark
pharmaceutical preparations treatment addiction urinary incontinence diabetes cardiovascular diseases disorders cerebrovascular diseases disorders anxiety depression insomnia cognitive disorders diseases disorders central nervous central nervous depressants central nervous stimulants
Abandonment Notice!
On Wednesday, September 10, 2014,
status on the IMPROLIP
trademark changed to Interruption of proceeding.
Apply Now for this name starting at $449!
CAUTION: Although Canada registration for this particular filing is inactive,
the mark may still enjoy common law rights, or may have been applied for again in a separate application.
Further research may be warranted to determine where this mark is truly abandoned in commerce.
On Wednesday, August 23, 2006, a canadian trademark registration was filed for
IMPROLIP by Merck Sharp & Dohme Corp. *********, **********, ***** ****.
The Canadian IP office has given the trademark application number of
1314107.
The current status of this trademark filing is Interruption of proceeding.
The correspondent listed for
IMPROLIP is
GOWLING WLG (CANADA) LLP of *********, **********, ***** ****
The IMPROLIP
trademark is filed in the description of
Pharmaceutical preparations for the treatment of addiction, urinary incontinence, diabetes, cardiovascular diseases and disorders, cerebrovascular diseases and disorders, anxiety, depression, insomnia, cognitive disorders, diseases and disorders of the central nervous system namely central nervous system depressants and central nervous system stimulants, gastrointestinal diseases and disorders, cancer, obesity, inflammation and inflammatory diseases namely anti-inflammatories, respiratory diseases and disorders, musculoskeletal disorders namely connective tissue diseases, arthritis and rheumatic disorders, osteoporosis, menopausal symptoms and disorders, anti-infective preparations, anti-viral preparations, immunological preparations for the treatment of immunological deficiencies, hypersensitivity and other allergic disorders, analgesic preparations, ophthalmic preparations and antiemetic preparations.
.
100% Satisfaction Guarantee
protect your valuable brand now.
Classification Information
Trademarkia is the largest search engine for U.S., China, European Union, Canada, and Australia Trademarks.
Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia network law firms!
You can
register your trademark in 180+ countries
in the world through Trademarkia Network. Trademarkia.com is a free search engine of publicly available government records.
Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.